QuietMIND Foundation (QMF) is a public non-profit applied neuroscience research foundation and consultation organization. Our mission: improving global healthcare and healthcare education by providing models and methods that enhance self advocacy and social maturity. QMF has studied and advocates the use of functional medicine, photobiomodulation and neurofeedback training and provides home-based equipment and remote consultation. QMF's consultats includes internationally recognized, highly-trained, professionals drawn from the fields of biofeedback and neuropsychology, neurophysiology, functional medicine, neuropsychiatry, neuroscience research, organizational consulting, and healthcare law.
We have a national and worldwide network of clinical healthcare professionals with whom we consult.
We train licensed professionals and graduate-level interns to conduct applied clinical research, including grant proposal development and design, as well as continuing education program delivery.
We have a national and worldwide network of clinical healthcare professionals with whom we consult.
We train licensed professionals and graduate-level interns to conduct applied clinical research, including grant proposal development and design, as well as continuing education program delivery.
|
|
Marvin H. Berman, Ph.D.,CBT,BCN Founder & President
Dr. Berman has a PhD in Psychoeducational Processes, where he studied group and organizational Psychology. He's a certified Bioenergetic Analyst with extensive training in Systems-Centered Therapy and the Feldenkrais Method, and certified in EEG biofeedback in 2003. Dr. Berman created the Neuradiant 1070nm photobiomodulation system and founded Neuronic Device Operations, GmbH with business co-founders. He now consults on the Neuromatrix transcranial PBM system, which is an advancement on the Neuradiant 1070 design. He is a recognized thought leader in photobiomodulation and neurofeedback, working to better understand and treat neurodegenerative, neurodevelopmental, and neuropsychiatric disorders.
|
James P Halper, MD, Neuropsychiatry & Immunology Consultant Dr. James Halper is a pioneer in psychoneuroimmunology and in applying QEEG and TMS in the treatment of psychiatric disorders. He was part of the team at NYU Dept. of Psychiatry who helped develop the first QEEG normative database and an early adopter of the Neurostar and Brainsway TMS systems for major depression and TBI. He i uniquely qualified to help patients understand how their immune system influences their cognition, mood, and behavior. |
Trent W Nichols, MD, Chairman, Quietmind Foundation Scientific Advisory Board
Dr. Nichols is a Northwestern University Med School grad and a Postdoc in Internal Medicine and Gastroenterology. His research has been in pharmaceutical clinical trials, nutraceuticals with "Optimal Digestive Health," a book for the public, and 2 textbooks.
He pioneered the development of moderate magnetic field therapy involving zero-point and 0.5T magnetic therapy for neurodegenerative disorders. He joined QMF to advance the development of self-administered applications of his pioneering work in noninvasive therapeutics. Dr. Nichols is also the Chief Medical Officer for the International Cancer Association for Education and Research (ICARE).
Dr. Nichols is a Northwestern University Med School grad and a Postdoc in Internal Medicine and Gastroenterology. His research has been in pharmaceutical clinical trials, nutraceuticals with "Optimal Digestive Health," a book for the public, and 2 textbooks.
He pioneered the development of moderate magnetic field therapy involving zero-point and 0.5T magnetic therapy for neurodegenerative disorders. He joined QMF to advance the development of self-administered applications of his pioneering work in noninvasive therapeutics. Dr. Nichols is also the Chief Medical Officer for the International Cancer Association for Education and Research (ICARE).
Adam Stamm Assistant Executive Director
Adam Stamm is an alumnus of Albright College. He has worked with Quietmind Foundation since 2019. Adam begin his involvement at Quietmind Foundation as a volunteer. He met Marvin Berman and learned about the Quietmind Foundation while traveling from Philadelphia, PA to Denver on a plane. He was fascinated by the concepts and research and couldn't wait to get involved.
Adam is responsible for helping manage various administrative tasks such as website updates, social media accounts, and QMF Newsletters. As a marketing and communications professional, Adam has helped to promote and organize research studies around photobiomodulation for QMF.
Adam Stamm is an alumnus of Albright College. He has worked with Quietmind Foundation since 2019. Adam begin his involvement at Quietmind Foundation as a volunteer. He met Marvin Berman and learned about the Quietmind Foundation while traveling from Philadelphia, PA to Denver on a plane. He was fascinated by the concepts and research and couldn't wait to get involved.
Adam is responsible for helping manage various administrative tasks such as website updates, social media accounts, and QMF Newsletters. As a marketing and communications professional, Adam has helped to promote and organize research studies around photobiomodulation for QMF.
Paul Chazot, PhD, QMF Scientific Advisory Board, Dept. of Biosciences, Durham University, Durham UK.
Dr. Chazot has produced a significant body of research on the mechanisms and clinical application of 1068- 1080nm pulsed photobiomodulation. He has been the basic science mentor for QMF and leading advocate for
the exploration of PBM as a potential disease-modifying intervention strategy, who with Dr. Gordon Dougal MD,
BSEE have been the driving force behind the development of the Cognitolite technology. Quietmind Fdn. was
fortunate to be chosen to conduct the first human clinical trials using the 1070nm PBMT device in 2009 and over
the next 15 years, now with our study partners at Baylor Research Institute in Temple, TX
Allan Lundy, Ph.D., IRB Chairman
Dr Lundy earned his PhD in Social Psychology from Harvard University in 1981. Between
1992 and 2003 he was on the faculty of the Department of Psychiatry at Jefferson Medical
College. During that time, he published 32 articles and book chapters. In his last six years at
Jefferson he was Principal Investigator on NIH and other grants totaling over two million
dollars. Since 2003 he has been an independent consultant in research methods and
statistical analysis.
Quietmind Foundation
Foundation Locations:
Philadelphia Office
Adam Stamm
Asst Executive Director
1819 S Hicks St
Philadelphia PA 19145
Please address postal mail to:
New Jersey Office (MAIN) Practice Location
145 La Quinta Dr. 501 Bay Ave. Ste. 108
Egg Harbor, NJ 08234 Somers Point, NJ 08422
Minnesota Neuroscience Laboratory
Jeffey Leighton, PhD, Chair, Psychology
North Central University
545 2nd St, Suite 532
Excelsior, MN 55331
Philadelphia Office
Adam Stamm
Asst Executive Director
1819 S Hicks St
Philadelphia PA 19145
Please address postal mail to:
New Jersey Office (MAIN) Practice Location
145 La Quinta Dr. 501 Bay Ave. Ste. 108
Egg Harbor, NJ 08234 Somers Point, NJ 08422
Minnesota Neuroscience Laboratory
Jeffey Leighton, PhD, Chair, Psychology
North Central University
545 2nd St, Suite 532
Excelsior, MN 55331
Support Quietmind Foundation's ongoing research!
Looking to help ensure our innovative clinical research continues? Please donate today!
Quietmind Fdn is an IRS-registered 501c3 nonprofit charity, all donations are fully tax deductible,
Quietmind Fdn is an IRS-registered 501c3 nonprofit charity, all donations are fully tax deductible,
